Drug Discovery
Boan Biotech's Investigational Anti-CD25 Antibody BA1106 Administered for First Patient in Phase I Clinical Trial
BA1106 is the first investigational anti-CD25 antibody to start clinical trials in China for treating solid tumors. Focusing on key therapeutic a...
February 13, 2023 | News
Everest Medicines Announces South Korea Grants Fast Track Review Designation to Nefecon for the Treatment of Primary IgA Nephropathy
This demonstrates the urgent unmet medical needs for Nefecon, as Everest also received Priority Review status for the New Drug Application (NDA) of Nefecon...
February 10, 2023 | News
Microba and BioAgilytix announce partnership to fast-track therapeutic delivery
Enables innovators to confidently leverage microbiome endpoints in clinical trials Delivers superior outcomes for clients at each stage of the d...
February 09, 2023 | News
Regulatory filing for house dust mite allergy tablet accepted for review in China
The BLA, for treatment of persistent moderate-to-severe HDM allergic rhinitis in patients aged 12–65 was submitted in late December 2022. S&...
February 03, 2023 | News
TransCure bioServices offers BioVolume 3D imaging for insightful preclinical oncology research
TransCure bioServices adds BioVolume 3D imaging to its service offerings, enabling them to deliver even higher quality tumor growth results to customers. W...
February 02, 2023 | News
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
Clinical development pipeline is essential to global business strategy Vetter Development Service offers comprehensive expertise for in-human trial mate...
February 02, 2023 | News
Amjevita™ (Adalimumab-atto), First Biosimilar to Humira®, Now Available in the United States
Amgen (NASDAQ:AMGN) announced AMJEVITA™ (adalimumab-atto), a biosimilar to Humira®* (adalimumab), is now available in the Un...
February 01, 2023 | News
Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China
Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and ...
February 01, 2023 | News
Lecanemab Receives Priority Review Status in Japan
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Chri...
January 30, 2023 | News
Alpha Biopharma Submits New Drug Application for Zorifertinib
Alpha Biopharma, a developer of innovative drugs, announces that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA...
January 30, 2023 | News
Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a g...
January 23, 2023 | News
ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production
Our valued customer Nouscom recently proclaimed that their sub-licensee, has initiated phase 1 clinical trials for VAC85135, a viral vector-based cancer va...
January 18, 2023 | News
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC
World's first anti-PD-1 mAb for the first-line treatment of SCLC Making a new record with the median OS of 15.8 months in an international, mult...
January 18, 2023 | News
Pharma Industry Trend Brief: 2023 Manufacturing Trends
Worried about what the future holds for the pharmaceutical industry? This trend brief examines how manufacturers can take advantage of mo...
January 18, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
